SNGX Soligenix, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 7, 2026
$0,37
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$0,28rendah 52m
$1,97tinggi 52m
Kapitalisasi Pasar (MRQ)
$8M
P/E
-0.2
EPS
$-2.14
Pendapatan
$119.4K
lencana Anda
Rentang 52M
$0–$2
Peringkat Analis
BUY
Target Harga
$1
P/E
-0.2
ROE
-311.2%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
SNGX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$0.37
Kapitalisasi Pasar (MRQ)
$8M
P/E
-0.2
EPS
$-2.14
Pendapatan
$119.4K
ROE
-311.2%
Rentang 52M
$0–$2
SNGX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 6 Juni 2024 | 1-for-16 | Terbalik |
| 10 Feb. 2023 | 1-for-15 | Terbalik |
| 7 Okt. 2016 | 1-for-10 | Terbalik |
| 1 Feb. 2012 | 1-for-20 | Terbalik |
| 11 Juni 1997 | 1-for-15 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$119.4K2021-12-31 → 2024-12-31
EPS$-2.142021-12-31 → 2025-12-31
Arus Kas Bebas$-10M2025-12-31 → 2025-12-31
Margin bersih·2021-12-31 → 2024-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | SNGX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -0.2 | · | · | · | |
| P/S | 8.1 | · | 12.6 | Terlalu mahal | |
| P/B (MRQ) | 1.2 | · | · | · | |
| Price / FCF (Harga / FCF) | -0.4 | · | · | · | |
| Price / Cash Flow (Harga / Arus Kas) | -0.4 | · | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 0.7 | · | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | SNGX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -121.8% | · | -126.8% | Sejajar | |
| ROE | -311.2% | · | -298.2% | Lemah | |
| ROIC | -214.0% | · | · | · |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | SNGX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 2.8 | · | 2.6 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | SNGX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | -85.8% | · | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | -47.5% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | SNGX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$9.2K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
2.1%
Laporan Berikutnya
Nov 05, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 12, 2026 | $-0.12 | $-0.16 | 24.1% |
| 31 Maret 2026 | Mei 7, 2026 | $-0.28 | $-0.29 | 2.0% |
| 31 Des. 2025 | $-0.28 | $-0.57 | 51.0% | |
| 30 Sep. 2025 | $-0.58 | $-0.57 | -2.5% | |
| 30 Juni 2025 | $-0.82 | $-0.94 | 12.6% | |
| 31 Maret 2025 | $-1.06 | $-0.68 | -55.1% | |
| 31 Des. 2024 | $-1.14 | $-0.97 | -17.6% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $119.4K | $839.4K | $948.9K | $824.3K | $2M | $5M | $5M | $5M | |
| Cost of Revenue | · | $119.4K | $742.0K | $550.8K | $728.6K | $2M | $4M | $5M | $4M | |
| Gross Profit | · | · | $97.3K | $398.1K | $95.6K | $538.5K | $1M | $643.7K | $1M | |
| R&D Expense | $7M | $5M | $3M | $8M | $8M | $10M | $8M | $7M | $6M | |
| SG&A Expense | $4M | $4M | $4M | $7M | $5M | $4M | $3M | $3M | $3M | |
| Operating Expenses | $12M | $9M | $8M | $15M | $13M | $19M | $12M | $10M | $9M | |
| Operating Income | $-12M | $-9M | $-8M | $-14M | $-13M | $-19M | $-11M | $-9M | $-8M | |
| Interest Income | · | · | · | · | · | · | $149.0K | $158.6K | · | |
| Other Non-op | $-11.7K | $549.8K | $-161.5K | $5.9K | $30.8K | $61.1K | $574.8K | $159.0K | · | |
| Pretax Income | $-12M | $-9M | $-8M | $-15M | $-13M | $-19M | $-10M | $-9M | $-8M | |
| Income Tax | $-506.6K | $-409.1K | $-2M | $-1M | $-864.7K | $-836.9K | $-610.7K | · | $-416.8K | |
| Net Income | $-11M | $-8M | $-6M | $-14M | $-13M | $-18M | $-9M | $-9M | $-7M | |
| EPS (Basic) | $-2.14 | $-4.98 | $-12.66 | $-4.81 | $-4.69 | $-0.64 | · | · | · | |
| EPS (Diluted) | $-2.14 | $-4.98 | $-12.66 | $-4.81 | $-4.69 | $-0.64 | · | · | · | |
| Shares (Basic) | 5,188,799 | 1,660,413 | 484,995 | 2,871,345 | 2,675,488 | 27,486,949 | · | · | · | |
| Shares (Diluted) | 5,188,799 | 1,660,413 | 484,995 | 2,871,345 | 2,675,488 | 27,486,949 | · | · | · | |
| EBITDA | $-12M | $-9M | $-8M | $-14M | $-13M | $-19M | $-10M | $-9M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | $26M | $19M | $5M | $9M | $8M | |
| Prepaid Expense | $894.3K | $905.3K | $866.0K | $274.2K | $282.9K | $225.5K | $609.7K | $157.3K | $263.3K | |
| Current Assets | $9M | $9M | $10M | $14M | $27M | $19M | $7M | $10M | $9M | |
| PP&E (Net) | $8.8K | $6.1K | $11.9K | $18.5K | $22.2K | $23.5K | $36.1K | $19.6K | $37.2K | |
| PP&E (Gross) | · | · | · | · | · | $154.8K | $135.0K | · | · | |
| Accum. Depreciation | · | · | $121.3K | $114.8K | $167.8K | $154.8K | · | · | · | |
| Intangibles | · | · | · | · | · | · | $19.7K | $46.9K | $74.0K | |
| Other Non-current Assets | · | · | · | · | $7.8K | $23.2K | $38.8K | · | · | |
| Total Assets | $9M | $9M | $10M | $14M | $27M | $20M | $8M | $10M | $10M | |
| Accounts Payable | $1M | $667.9K | $1M | $4M | $3M | $2M | $3M | $2M | $2M | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $1M | |
| Short-term Debt | · | · | · | · | · | $325.0K | · | · | · | |
| Current Liabilities | $4M | $5M | $6M | $17M | $6M | $6M | $6M | $4M | $3M | |
| Capital Leases | $244.1K | · | $111.9K | $233.6K | · | · | · | · | · | |
| Total Liabilities | $4M | $5M | $7M | $17M | $16M | $16M | $6M | $4M | · | |
| Long-term Debt | · | $0 | $1M | $0 | · | · | · | · | · | |
| Total Debt | · | · | · | · | · | $325.0K | · | · | · | |
| Common Stock | $10.1K | $2.5K | $649 | $2.9K | $2.9K | $30.6K | $21.8K | $17.7K | $8.7K | |
| Paid-in Capital | $250M | $238M | $228M | $217M | $216M | $197M | $177M | $172M | $164M | |
| Retained Earnings | $-245M | $-234M | $-226M | $-220M | $-206M | $-193M | $-176M | $-166M | $-157M | |
| AOCI | $45.8K | $45.8K | $22.2K | $24.7K | $41.9K | $-24.3K | $-45.0K | $-3.7K | · | |
| Stockholders' Equity | $5M | $4M | $3M | $-2M | $11M | $4M | $1M | $6M | $6M | |
| Liabilities + Equity | $9M | $9M | $10M | $14M | $27M | $20M | $8M | $10M | $10M | |
| Shares Outstanding | 10,086,130 | 2,514,499 | 648,761 | 2,908,578 | 2,858,244 | 30,643,656 | 21,753,124 | 17,682,839 | 8,730,640 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $34.2K | $62.4K | $54.5K | $44.1K | $68.6K | |
| Stock-based Comp | $587.6K | $329.8K | $370.2K | $333.4K | $361.6K | $409.9K | $376.3K | $380.9K | $489.8K | |
| Amort. of Intangibles | · | · | · | · | · | $19.7K | $27.2K | $27.1K | $52.7K | |
| Other Non-cash | · | · | · | · | $415.6K | $6M | $1M | $1M | · | |
| Operating Cash Flow | $-10M | $-8M | $-9M | $-13M | $-12M | $-11M | $-8M | $-7M | $-7M | |
| CapEx | $5.9K | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | $-5.9K | · | · | $-13.1K | $-11.8K | $-7.1K | $-24.7K | $-925 | $-26.3K | |
| Financing Cash Flow | $10M | $8M | $4M | $76.8K | $19M | $25M | $4M | $8M | $6M | |
| Net Change in Cash | $116.6K | $-626.6K | $-5M | $-13M | $7M | $13M | $-4M | $1M | $-963.1K | |
| Free Cash Flow | $-10M | · | · | · | · | · | · | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 11.6% | 41.9% | 11.6% | 22.8% | 22.9% | 12.3% | · | |
| Operating Margin | · | -7907.7% | -917.1% | -1500.5% | -1594.2% | -787.8% | -227.7% | -172.8% | · | |
| Net Margin | · | -6925.1% | -731.6% | -1454.1% | -1522.7% | -749.7% | -202.1% | -169.8% | · | |
| Pretax Margin | · | -7267.8% | -942.2% | -1575.8% | -1627.6% | -785.2% | -215.3% | -169.8% | · | |
| EBITDA Margin | · | -7907.7% | -917.1% | -1500.5% | -1590.1% | -785.1% | -226.5% | -172.0% | · | |
| ROA | -121.8% | -85.0% | -51.0% | -67.1% | -53.7% | -127.9% | -102.4% | -88.8% | · | |
| ROE | -311.2% | -164.5% | -182.1% | 1918.0% | -97.4% | -317.4% | -452.6% | -114.5% | · | |
| ROIC | -214.0% | -218.4% | -237.0% | 531.8% | -114.7% | -436.4% | -679.1% | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 1.8 | 1.5 | 0.8 | 4.2 | 3.2 | 1.2 | 2.5 | · | |
| Quick Ratio | · | · | · | · | 4.1 | 3.1 | 0.9 | 2.1 | · | |
| Debt / Equity | · | · | · | · | · | 0.1 | · | · | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.1 | 0.0 | 0.0 | 0.2 | 0.5 | 0.5 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.52 | $1.64 | $0.24 | $-0.85 | $0.25 | $0.12 | $0.07 | $0.36 | · | |
| Revenue / Share | · | $0.07 | $0.11 | $0.33 | $0.02 | · | · | · | · | |
| Cash Flow / Share | $-1.98 | $-5.06 | $-1.11 | $-4.41 | $-0.29 | · | · | · | · | |
| Cash / Share | · | · | · | · | $0.61 | $0.61 | $0.25 | $0.51 | · | |
| EPS (TTM) | $-2.14 | $-4.98 | $-12.66 | $-4.81 | $-4.69 | $-0.64 | · | · | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | -85.8% | -11.6% | 15.1% | -65.1% | · | · | · | · | |
| Revenue CAGR 3Y | · | -47.5% | -29.1% | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $456.7K | $119.4K | $839.4K | $948.9K | $824.3K | $2M | $5M | $5M | $5M | |
| Net Income TTM | $-11M | $-8M | $-6M | $-14M | $-13M | $-18M | $-9M | $-9M | $-7M | |
| Market Cap | $14M | $7M | $126M | $314M | $6.79B | $9.41B | $7.57B | $3.65B | · | |
| Enterprise Value | · | · | · | · | · | $9.40B | · | · | · | |
| P/E | -0.6 | -0.5 | -1.0 | -22.5 | -33.8 | -480.0 | · | · | · | |
| P/S | 29.6 | 56.9 | 150.4 | 331.0 | 8239.0 | 3989.8 | 1635.0 | 696.3 | · | |
| P/B | 2.6 | 1.6 | 50.0 | -127.1 | 633.3 | 2515.8 | 5195.2 | 581.2 | · | |
| P / Tangible Book | 2.6 | 1.6 | 50.0 | · | 633.3 | 2515.8 | · | · | · | |
| P / Cash Flow | -1.3 | -0.8 | -14.7 | -24.8 | -578.5 | -821.8 | -1008.1 | -503.8 | · | |
| P / FCF | -1.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | · | · | · | · | · | -507.2 | · | · | · | |
| EV / Revenue | · | · | · | · | · | 3982.0 | · | · | · | |
| Earnings Yield | -159.7% | -184.4% | -104.1% | -4.5% | -3.0% | -0.21% | · | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $2.3K | $117.0K | $244.8K | $130.4K | $206.9K | $257.2K | $366.1K | $166.1K | |
| Cost of Revenue | · | · | · | · | · | · | $0 | $0 | $2.3K | $117.0K | $221.5K | $110.4K | $184.0K | $226.0K | $135.9K | $129.4K | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | $23.3K | $20.0K | $22.9K | $31.1K | $230.2K | $36.7K | |
| R&D Expense | $974.1K | $2M | $2M | $2M | $2M | $2M | $3M | $968.7K | $501.2K | $1M | $777.5K | $826.0K | $762.7K | $946.5K | $2M | $2M | |
| SG&A Expense | $1M | $1M | $1M | $996.6K | $1M | $1M | $1M | $896.5K | $1M | $1M | $1M | $973.0K | $890.5K | $1M | $1M | $1M | |
| Operating Expenses | $2M | $3M | $3M | $3M | $3M | $3M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $3M | |
| Operating Income | $-2M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-4M | $-3M | |
| Other Non-op | $58.5K | $-1.5K | $-166 | $-2.8K | $-7.9K | $-788 | $245.6K | $67.0K | $64.2K | $172.9K | $-204.7K | $0 | $2.4K | $40.9K | · | · | |
| Pretax Income | $-2M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-4M | $-3M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | $-606.6K | $0 | $0 | $-1M | $0 | $-1M | |
| Net Income | $-2M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | $-4M | $-3M | |
| EPS (Basic) | $-0.12 | $-0.28 | $0.23 | $-0.58 | $-0.82 | $-0.97 | $0.02 | $-0.78 | $-1.31 | $-2.91 | $-6.18 | $-2.56 | $-3.56 | $-0.36 | $-1.31 | $-1.15 | |
| EPS (Diluted) | $-0.12 | $-0.28 | $0.23 | $-0.58 | $-0.82 | $-0.97 | $0.02 | $-0.78 | $-1.31 | $-2.91 | $-6.18 | $-2.56 | $-3.56 | $-0.36 | $-1.31 | $-1.15 | |
| Shares (Basic) | 15,951,949 | 10,164,898 | · | 4,329,649 | 3,278,677 | 3,049,625 | · | 2,203,929 | 1,258,985 | 657,698 | · | 648,860 | 453,035 | 2,914,929 | · | 2,872,262 | |
| Shares (Diluted) | 15,951,949 | 10,164,898 | · | 4,329,649 | 3,278,677 | 3,049,625 | · | 2,203,929 | 1,258,985 | 657,698 | · | 648,860 | 453,035 | 2,914,929 | · | 2,872,262 | |
| EBITDA | $-2M | $-3M | · | $-3M | $-3M | $-3M | · | $-2M | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-3M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prepaid Expense | $355.5K | $437.1K | $894.3K | $355.6K | $191.1K | $299.7K | $905.3K | $340.3K | $244.5K | $451.9K | $866.0K | $584.4K | $171.3K | $213.3K | $274.2K | $396.4K | |
| Current Assets | $10M | $7M | $9M | $11M | $5M | $8M | $9M | $10M | $10M | $8M | $10M | $11M | $13M | $11M | $14M | $17M | |
| PP&E (Net) | $6.6K | $7.7K | $8.8K | $7.8K | $8.1K | $5.5K | $6.1K | $7.2K | $8.8K | $10.3K | $11.9K | $13.5K | $15.1K | $16.7K | $18.5K | $21.5K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $119.7K | $118.1K | $116.6K | $114.8K | $111.7K | |
| Total Assets | $10M | $7M | $9M | $11M | $6M | $8M | $9M | $10M | $10M | $8M | $10M | $11M | $14M | $11M | $14M | $18M | |
| Accounts Payable | $1M | $828.7K | $1M | $1M | $650.0K | $599.7K | $667.9K | $891.2K | $2M | $1M | $1M | $1M | $2M | $3M | $4M | $4M | |
| Accrued Liabilities | $2M | $3M | $2M | $2M | $3M | $3M | $2M | $1M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Current Liabilities | $4M | $4M | $4M | $3M | $4M | · | $5M | $5M | $6M | $7M | $6M | $6M | $6M | $11M | $17M | $10M | |
| Capital Leases | $182.1K | $213.4K | $244.1K | $273.9K | $302.6K | · | · | $11.5K | $45.7K | $79.1K | $111.9K | $143.7K | $174.3K | $204.3K | $233.6K | $262.1K | |
| Total Liabilities | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $6M | $7M | $7M | $7M | $8M | $14M | $17M | $17M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $1M | $1M | $2M | · | $0 | · | |
| Common Stock | $21.6K | $10.5K | $10.1K | $9.9K | $3.5K | $3.2K | $2.5K | $2.3K | $1.5K | $10.5K | $649 | $10.4K | $9.8K | $2.9K | $2.9K | $43.1K | |
| Paid-in Capital | $256M | $251M | $250M | $250M | $241M | $241M | $238M | $237M | $233M | $228M | $228M | $228M | $228M | $217M | $217M | $217M | |
| Retained Earnings | $-250M | $-248M | $-245M | $-242M | $-240M | $-237M | $-234M | $-231M | $-229M | $-228M | $-226M | $-224M | $-222M | $-221M | $-220M | $-216M | |
| AOCI | $45.8K | $45.8K | $45.8K | $45.8K | $45.8K | $45.8K | $45.8K | $37.5K | $27.6K | $24.1K | $22.2K | $24.3K | $6.1K | $12.6K | $24.7K | $25.5K | |
| Stockholders' Equity | $7M | $3M | $5M | $8M | $2M | $4M | $4M | $6M | $3M | $768.4K | $3M | $4M | $6M | $-3M | $-2M | $1M | |
| Liabilities + Equity | $10M | $7M | $9M | $11M | $6M | $8M | $9M | $10M | $10M | $8M | $10M | $11M | $14M | $11M | $14M | $18M | |
| Shares Outstanding | 21,637,479 | 10,518,269 | 10,086,130 | 9,861,130 | 3,504,950 | 3,183,992 | 2,514,499 | 2,295,304 | 1,542,480 | 10,524,437 | 648,761 | 10,378,238 | 9,841,854 | 2,929,773 | 2,908,578 | 43,105,191 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $116.0K | $121.2K | $320.1K | $104.3K | $99.5K | $63.6K | $155.5K | $56.6K | $57.7K | $60.0K | $141.1K | $65.4K | $90.0K | $73.6K | $112.7K | $70.7K | |
| Operating Cash Flow | $-2M | $-2M | $-3M | $-3M | $-3M | $-2M | $-2M | $-3M | $-2M | $-1M | $-2M | $-3M | $-2M | $-2M | $-4M | $-3M | |
| CapEx | · | · | $2.0K | $608 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | · | · | $-2.0K | $-608 | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Financing Cash Flow | $5M | $451.0K | $157.9K | $8M | $545.6K | $1M | $242.9K | $3M | $4M | $-9.0K | $-46.2K | $-175.3K | $5M | $-931.6K | · | · | |
| Net Change in Cash | $4M | $-2M | $-3M | $5M | $-2M | $-522.3K | $-2M | $427.6K | $2M | $-1M | $-2M | $-3M | $3M | $-3M | $-4M | $-3M |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | 15.3% | 11.1% | 12.1% | · | 22.1% | |
| Operating Margin | · | · | · | · | · | · | · | · | -74495.1% | -1809.0% | · | -1363.9% | -787.9% | -836.3% | · | -1854.6% | |
| Net Margin | · | · | · | · | · | · | · | · | -70217.9% | -1636.6% | · | -1274.7% | -779.0% | -406.8% | · | -1991.7% | |
| Pretax Margin | · | · | · | · | · | · | · | · | -70217.9% | -1636.6% | · | -1274.7% | -779.0% | -858.3% | · | -1991.7% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -74495.1% | -1809.0% | · | -1363.9% | -787.9% | -836.3% | · | -1854.6% | |
| ROA | -24.4% | -38.5% | · | -23.2% | -34.6% | -41.0% | · | -15.8% | -13.9% | -20.0% | · | -11.4% | -9.2% | -6.0% | · | -13.9% | |
| ROE | -46.9% | -84.3% | · | -37.4% | -102.1% | -147.8% | · | -33.9% | -35.5% | 146.3% | · | -63.3% | -32.2% | -65.4% | · | -41.1% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | · | · | 30.1% | · | -194.4% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 1.8 | · | 3.2 | 1.5 | · | · | 2.3 | 1.5 | 1.1 | · | 2.0 | 2.3 | 0.9 | · | 1.8 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.31 | $0.29 | · | $0.77 | $0.52 | $1.13 | · | $2.59 | $2.25 | $0.07 | · | $0.41 | $0.59 | $-1.16 | · | $0.02 | |
| Revenue / Share | · | · | · | · | · | · | · | · | $0.00 | $0.01 | · | $0.01 | $0.03 | $0.09 | · | $0.00 | |
| Cash Flow / Share | · | $-0.23 | · | · | · | $-0.61 | · | · | · | $-0.13 | · | · | · | $-0.74 | · | · | |
| EPS (TTM) | $-0.75 | $-1.45 | · | $-2.35 | $-2.55 | $-3.04 | · | $-11.18 | $-12.96 | $-15.21 | · | $-7.79 | $-6.38 | $-3.65 | · | $-7.99 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $119.4K | $119.4K | · | $119.4K | $119.4K | $119.4K | · | $364.2K | $494.6K | $699.2K | · | $960.6K | $996.3K | $1M | · | $858.5K | |
| Net Income TTM | $-10M | $-11M | · | $-11M | $-10M | $-9M | · | $-7M | $-7M | $-7M | · | $-8M | $-10M | $-10M | · | $-15M | |
| Market Cap | $9M | $12M | · | $11M | $5M | $7M | · | $9M | $4M | $101M | · | $93M | $110M | $92M | · | $4.55B | |
| P/E | -0.5 | -0.8 | · | -0.5 | -0.5 | -0.7 | · | -0.4 | -0.2 | -0.6 | · | -1.2 | -1.8 | -8.6 | · | -13.2 | |
| P/S | 72.5 | 104.0 | · | 95.8 | 38.5 | 57.3 | · | 25.0 | 8.0 | 144.5 | · | 96.8 | 110.6 | 90.7 | · | 5302.2 | |
| P/B | 1.3 | 4.0 | · | 1.5 | 2.5 | 1.9 | · | 1.5 | 1.1 | 131.5 | · | 22.0 | 19.0 | -27.3 | · | 4410.8 | |
| P / Tangible Book | 1.3 | 4.0 | · | 1.5 | 2.5 | 1.9 | · | 1.5 | 1.1 | 131.5 | · | 22.0 | 19.0 | · | · | 4410.8 | |
| P / Cash Flow | · | -5.3 | · | · | · | -3.7 | · | · | · | -75.3 | · | · | · | -42.6 | · | · | |
| Earnings Yield | -187.5% | -122.9% | · | -202.6% | -194.7% | -141.4% | · | -281.6% | -502.3% | -158.4% | · | -86.9% | -57.0% | -11.6% | · | -7.6% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Pendapatan | · | · | · | $119.4K | · |
| Margin Operasi % | · | · | · | -7907.7% | · |
| Laba Bersih | $-11M | · | · | $-8M | · |
| EPS Dilusian | $-2.14 | · | · | $-4.98 | · |
| Metrik | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Rasio Lancar | 2.4 | · | · | 1.8 | · |
| Metrik | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-10M | · | · | · | · |
Pemilik institusional (13F) 20 pengaju · $460K total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
20
Nilai yang dipegang
$460K
Posisi baru
6
Posisi yang keluar
3
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 6 (+2 vs Kuartal sebelumnya) | 3 (-2 vs Kuartal sebelumnya) | 3 (0 vs Kuartal sebelumnya) | 3 (0 vs Kuartal sebelumnya) | +673K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| VANGUARD GROUP INC | $114.527 | 85.468 | 24,89% | Saham |
| CITADEL ADVISORS LLC | $82.965 | 209.507 | 18,03% | Saham |
| JANE STREET GROUP, LLC | $82.166 | 207.492 | 17,86% | Saham |
| XTX Topco Ltd | $62.219 | 157.119 | 13,52% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $47.624 | 120.267 | 10,35% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $32.078 | 81.005 | 6,97% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $21.350 | 53.914 | 4,64% | Saham |
| NORTHERN TRUST CORP | $15.066 | 38.046 | 3,27% | Saham |
| MORGAN STANLEY | $1.422 | 3.592 | 0,31% | Saham |
| JONES FINANCIAL COMPANIES LLLP | $507 | 1.236 | 0,11% | Saham |
| JPMORGAN CHASE & CO | $98 | 245 | 0,02% | Saham |
| Plante Moran Financial Advisors, LLC | $83 | 209 | 0,02% | Saham |
| Virtu Financial LLC | $24 | 60.903 | 0,01% | Saham |
| CWM, LLC | $7 | 6 | 0,00% | Saham |
| ALBION FINANCIAL GROUP /UT | $1 | 1 | 0,00% | Saham |
| SBI Securities Co., Ltd. | $1 | 2 | 0,00% | Saham |
| OSAIC HOLDINGS, INC. | $0 | 1 | 0,00% | Saham |
| ROYAL BANK OF CANADA | $0 | 5 | 0,00% | Saham |
| Caitong International Asset Management Co., Ltd | $0 | 1 | 0,00% | Saham |
| Motiv8 Investments LLC | $0 | 3 | 0,00% | Saham |
Aktivis & pemilik 5%+ 16 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Paolo Cavazza (2), Essetifin S.p.A. (2), Leadiant Biosciences, Inc. (2), Enrico Cavazza (2), Francesca Cavazza (2), Silvia Cavazza (2), Martina Cavazza Preta (2) ×29 pengajuan | 1 Des. 2017 | · | Pengajuan awal | · | SEC |
| RANDAL J. KIRK, THIRD SECURITY, LLC, NRM VII HOLDINGS I, LLC, INTREXON CORPORATION ×6 pengajuan | 16 Juni 2017 | · | Pengajuan awal | · | SEC |
| Cyrille F. Buhrman | 2 Juli 2007 | · | Pengajuan awal | Investasi pasif | SEC |
| Elan Corporation, plc, Elan International Services Ltd., Elan Pharmaceutical Investments, Ltd. ×3 pengajuan | 13 Feb. 2006 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 19 Feb. 2004 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 19 Feb. 2004 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 19 Feb. 2004 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 13 Feb. 2004 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 13 Feb. 2004 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 13 Feb. 2004 | · | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 13 Feb. 2004 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 6 Feb. 2004 | · | Pengajuan awal | Kampanye dewan | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 6 Feb. 2004 | · | Pengajuan awal | Kampanye dewan | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 6 Feb. 2004 | · | Pengajuan awal | Kampanye dewan | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 23 Mei 2002 | · | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan | 23 Mei 2002 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 36 orang dalam · 13 pejabat · 21 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Christopher J Schaber | CHAIRMAN, CEO AND PRESIDENT | 11 Des. 2025 A | 15.511 | 1 | 0 | $19.974 |
| Michael T Sember | Chief Executive Officer | 10 April 2006 A | 180.440 | 0 | 0 | $0 |
| Jonathan L. Guarino | CFO | 11 Des. 2025 A | 11.000 | 0 | 0 | $0 |
| Karen R Krumeich | SVP and CFO | 13 Des. 2018 A | · | 0 | 0 | $0 |
| Joseph Michael Warusz | VP of Finance/Acting CFO | 31 Des. 2015 A | 12.955 | 0 | 0 | $0 |
| Evan Myrianthopoulos | Sr VP and CFO | 1 Des. 2011 A | 224.780 | 0 | 0 | $0 |
| Oreola Donini | CSO | 11 Des. 2025 A | · | 0 | 0 | $0 |
| Richard Straube | CMO (Consulting) | 11 Des. 2025 A | 8.000 | 0 | 0 | $0 |
| Robert N Brey | Chief Scientific Off., Sr. VP | 5 Des. 2013 A | · | 0 | 0 | $0 |
| Kevin Horgan | Chief Medical Officer & Sr. VP | 25 Sep. 2013 A | · | 0 | 0 | $0 |
| Brian L Hamilton | Chief Medical Officer & Sr VP | 23 Sep. 2010 A | · | 0 | 0 | $0 |
| Christopher P. Schnittker | VP-Admin., Controller | 23 Sep. 2010 A | · | 0 | 0 | $0 |
| James Clavijo | Controller/Treasurer | 18 Des. 2008 A | 88.191 | 0 | 0 | $0 |
| Diane L. Parks | Direktur | 17 Sep. 2026 A | 14.940 | 0 | 0 | $0 |
| Jerome B Zeldis | Direktur | 17 Sep. 2026 A | 22.917 | 0 | 0 | $0 |
| Robert J. Rubin | Direktur | 17 Sep. 2026 A | 4.385 | 0 | 0 | $0 |
| Anthony Gregg Lapointe | Direktur | 17 Sep. 2026 A | 73.781 | 0 | 0 | $0 |
| Timothy R. Cote | Direktur | 3 Mei 2023 A | · | 0 | 0 | $0 |
| Mark E. Pearson | Direktur | 6 Sep. 2019 A | 78.338 | 0 | 0 | $0 |
| Keith L Brownlie | Direktur | 27 Sep. 2018 A | 50.000 | 0 | 0 | $0 |
| Marco Maria Brughera | Direktur | 8 Juni 2017 A | 2.750 | 0 | 0 | $0 |
| Virgil Thompson | Direktur | 22 Juni 2011 A | · | 0 | 0 | $0 |
| Tamar D Howson | Direktur | 22 Juni 2011 A | · | 0 | 0 | $0 |
| Cyrille F Buhrman | Direktur | 4 Juni 2009 A | · | 0 | 0 | $0 |
| James S Kuo | Direktur | 4 Juni 2009 A | · | 0 | 0 | $0 |
| KANZER STEVE H | Direktur | 9 Feb. 2007 P | 1.282.203 | 0 | 0 | $0 |
| T J Madison | Direktur | 10 Jan. 2006 A | · | 0 | 0 | $0 |
| Alexander P Haig | Direktur | 10 Jan. 2006 A | · | 0 | 0 | $0 |
| Peter Salomon | Direktur | 9 Sep. 2004 A | 415.000 | 0 | 0 | $0 |
| Arthur Asher Kornbluth | Direktur | 9 Sep. 2004 A | · | 0 | 0 | $0 |
| Peter Salomon MD | Direktur | 15 Sep. 2003 A | · | 0 | 0 | $0 |
| Paolo Cavazza | Pemilik 10% | 20 Des. 2012 J | 3.282.929 | 0 | 0 | $0 |
| Claudio Cavazza | Pemilik 10% | 18 Juni 2010 J | 54.227.816 | 0 | 0 | $0 |
| Biotex Pharma Investments, LLC | Pemilik 10% | 18 Sep. 2009 D | 18.750.000 | 0 | 0 | $0 |
| Larry Kessel | · | 9 Sep. 2004 A | · | 0 | 0 | $0 |
| Alexander M Jr General Usa Ret Haig | · | 9 Sep. 2004 A | · | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 1 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 81.005 SH | 19 Agu 2026 | Harian |
SNGX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 7 analis
BELI
Target median
$1.38
+276,3%
2 28,6%
Beli Kuat
4 57,1%
Beli
1 14,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
2 analis · 2026-10-02Target rata-rata $1.38 +276,3%
← Di bawah semua target
Harga saat ini $0.37
Rendah$1.25
Rata-rata$1.38
Tinggi$1.50
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| SNGX | $14M | -0.6 | -85.8% | · | -311.2% | · |
| FBLG | · | -0.5 | · | · | · | · |
| LGVN | · | -0.4 | -49.9% | -1893.6% | -247.7% | 67.0% |
| ENSC | $4M | -0.2 | -2.8% | -200.9% | -294.0% | · |
| KALA | $15M | -0.2 | · | · | -1423.8% | · |
| SKYE | $25M | -0.5 | · | · | -175.6% | · |
| IMNN | $13M | -0.6 | · | · | -298.2% | · |
| BIAF | · | · | · | · | · | · |
| ACXP | $6M | -0.5 | · | · | -180.3% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 7, 2026